The modern era of biobased innovation was catalyzed by policy action. In 1999, President Bill Clinton issued Executive Order ...
Following submissions from both sides, Mohali chief judicial magistrate Megha Dhaliwal dismissed the VB’s application for ...
Chloroplasts—the "light power plants" of plant cells—are increasingly the focus of synthetic biology. These organelles house ...
Medical technology, the pharmaceutical industry and biotechnology are sectors in which sensors and measurement technology are increasingly being used to improve quality and efficiency. Micro-Epsilon ...
UD chemical engineer wins the AIChE Langer Prize for efforts to harness biology to manage plastic waste sustainably ...
A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.
Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for serious and rare diseases, today ...
The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.
Advancing preparations to begin manufacturing of fibroblast-based spheroids product candidate, CYWC628, for the Phase 1/2 clinical trial evaluating CYWC628 in diabetic foot ulcers (DFU) patients Prepa ...
AI in Computer-Aided Synthesis Planning Market reached USD 2.13 bn in 2024 and is expected to grow rapidly to USD 68.06 bn by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback